Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wellbutrin XL in dysthymic disorder
NCT00225251Phase 4Completed
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Start
- Nov 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in persistent depressive disorder (PDD) comparing bupropion XL with Placebo (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 10 weeks. Started Nov 2004; status: completed.
02
Drugs
bupropion
03
Conditions
persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00225251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225251.